Direktorat Registrasi ObatValid

LIDOCAINE COMPOSITUM

BPOM Number: GKL1910402743A1
Approved: 17 September 2024
Expiry: 14 August 2025
Form: INJEKSI; 0,0260 MG /21,960 MG

About This Registration

LIDOCAINE COMPOSITUM is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1910402743A1. Its current registration status is Valid, with the licence valid until 14 August 2025. The product is registered to IPHA LABORATORIES - INDONESIA. BPOM first approved this registration in August 2020. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 30 AMPUL @ 2 ML
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

IPHA LABORATORIES - INDONESIA
KAB. BANDUNG BARAT
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

IPHA LABORATORIES - INDONESIA
KAB. BANDUNG BARAT
primary
View profile →

Ingredients (1)

EPINEPHRINE BITARTRATE. LIDOCAINE HYDROCHLORIDE MONOHYDRATE

Market Intelligence

Owner Portfolio: IPHA LABORATORIES - INDONESIA holds 31 BPOM registrations
Manufacturer Scale: IPHA LABORATORIES - INDONESIA produces 31 registered products
Registration Age: Registered for 6 years, 1 month
Expiry Status: Expired 409 days ago